Axovant Gene Therapies
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch AXGT and buy or sell other stocks, ETFs, and their options commission-free!About AXGT
Sio Gene Therapies, Inc. is a clinical-stage biopharmaceutical company, which engages in the acquisition, development, and commercialization of gene therapies for neurological diseases. The company was founded on October 31, 2014 and is headquartered in New York, NY.
CEODavid W. Nassif
CEODavid W. Nassif
Employees—
Employees—
HeadquartersNew York, New York
HeadquartersNew York, New York
Founded2014
Founded2014
Employees—
Employees—
AXGT Key Statistics
Market cap35.36M
Market cap35.36M
Price-Earnings ratio-1.22
Price-Earnings ratio-1.22
Dividend yield—
Dividend yield—
Average volume218.56K
Average volume218.56K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$0.50
52 Week high$0.50
52 Week low$0.25
52 Week low$0.25
Stock Snapshot
As of today, Axovant Gene Therapies(AXGT) shares are valued at $0.40. The company's market cap stands at 35.36M, with a P/E ratio of -1.22.
On 2025-12-19, Axovant Gene Therapies(AXGT) stock opened at —, reached a high of —, and a low of —.
The Axovant Gene Therapies(AXGT)'s current trading volume is 0, compared to an average daily volume of 218.56K.
During the past year, Axovant Gene Therapies(AXGT) stock moved between $0.25 at its lowest and $0.50 at its peak.
During the past year, Axovant Gene Therapies(AXGT) stock moved between $0.25 at its lowest and $0.50 at its peak.
People also own
Based on the portfolios of people who own AXGT. This list is generated using Robinhood data, and it’s not a recommendation.